Precision BioSciences Inc expected to post a loss of $1.92 a share - Earnings Preview

Precision Biosciences

01/11/2024 13:57

* Precision BioSciences Inc  DTIL.OQ   DTIL.O  is expected
to show
a fall in quarterly revenue when it reports  results on November
4 for the period ending January 1 0001
    * The Durham North Carolina-based  company is expected to
report a
51.6% decrease in revenue to $6.356 million from $13.12 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Precision BioSciences
Inc is
for a loss of $1.92 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Precision
BioSciences Inc is 30.00​, above​ its last closing price
of $8.56. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -1.68       -1.50      4.67      Beat    410.3
 Mar. 31 2024  -2.01       -1.91      -0.35     Beat    81.7
 Jan. 1 0001   -3.99       -2.05      -4.06     Missed  -98.3​
 Sep. 30 2023  -5.03       -4.87      -2.10     Beat    56.9
 ​​Jun.        -7.52       -7.32      -3.00     Beat    59
 30 2023                                                
 Mar. 31 2023  -6.80       -6.78      -6.90     Missed  -1.8​
 Dec. 31 2022  -6.48       -6.22      -6.60     Missed  -25.3
 Sep. 30 2022  -7.63       -7.95      -6.60     Beat    17
 This summary was machine generated November 1 at 13:56 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)